We investigated the radiosensitizing effect of pemigatinib on two radioresistant GBM cell lines with different MGMT methylation statuses: U87 (MGMT-methylated) and LN18 (MGMT-unmethylated). The gene discussed is MGMT; the disease is glioblastoma.